<DOC>
	<DOCNO>NCT02212067</DOCNO>
	<brief_summary>This trial conduct Europe . The aim trial investigate effect semaglutide ß-cell function subject type 2 diabetes .</brief_summary>
	<brief_title>A Trial Investigating Effects Semaglutide ß-cell Function Subjects With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Age : 1864 year ( inclusive ) time sign informed consent For subject type 2 diabetes : Male female subject diagnose type 2 diabetes Treated diet exercise and/or metformin monotherapy . Metformin dose unchanged period 30 day prior screen Body Mass Index ( BMI ) 20.035.0 kg/m^2 ( inclusive ) Glycosylated haemoglobin ( HbA1c ) 6.59.0 % ( inclusive ) For healthy control group grade glucose infusion : Healthy male female subject BMI 24.032.0 kg/m^2 ( inclusive ) HbA1c le 6.5 % Female pregnant , breastfeed intend become pregnant child bear potential use adequate contraceptive method . Women child bear potential must use effective method birth control duration trial subject type 2 diabetes 5 week follow last dose semaglutide . Only highly effective method birth control accept ( i.e . one result less 1 % per year failure rate use consistently correctly implant , injectables , combine oral contraceptive , intrauterine device ) , sexual abstinence vasectomise partner Any clinically significant disease history , opinion investigator , systemic organ disease include : cardiac , pulmonary , gastrointestinal , hepatic , neurologic , renal , genitourinary endocrine , dermatologic hematologic Use prescription nonprescription medication could interfere trial pharmacokinetic pharmacodynamic result , judge investigator specifically : ) current treatment systemic ( oral i.v . ) corticosteroid , nonselective betablockers , b ) thyroid hormone allow unless use stable past 2 month prior screen History drug/chemical substance abuse within 1 year prior screening , positive result urine drug test History alcohol abuse within 1 year prior screening , positive result alcohol breath test Smoker ( define subject smoke 5 cigarette equivalent per day ) Not able willing refrain smoking use nicotine gum transdermal nicotine patch inpatient period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>